​​​​Mr. Clinton A. Campos Hess graduated from the Wharton School of the University of Pennsylvania (Pennsylvania, USA) with a Bachelor of Science degree in Economics, with Dual Majors in Multinational Management and Finance. He was first appointed as President Commissioner at the AGMS held on ​June 2019. He has served as a Commissioner of the Company since June 2006 and was a Director of the Company in 2005. Mr. Campos Hess joined the management team of the Unilab and Unam Group of Companies in 1993. Currently, he serves as Vice Chairman, President and CEO of both Unilab and Unam, Chairman of the Board of Univet Nutrition and Animal Healthcare Company (UNAHCO), President Director of PT Etana Biotechnologies Indonesia, Vice President Commissioner of PT Medifarma Laboratories, as well as President Commissioner of PT Medifarma Life Sciences.

Mr. Eric Albert Lim Gotuaco was appointed as a Vice President Commissioner in June 2019. Mr. Eric Got​uaco is a Filipino citizen, born in 1968. He attended The Wharton School, University of Pennsylvania, graduating in 1990 with a B.S. in Economics, Magna Cum Laude. He began his career as an Analyst in the Structured Finance Group at Goldman, Sachs & Co., New York in 1989 to 1992. Thereafter, he was an Associate at Hambrecht & Quist Philippines, Inc. from 1992 to 1993. Before joining Unilab, Inc. in 2002, he started First Choice Food Corporation in 1993 and was President up to 2002. In 2006, he was appointed Director of the Company, and subsequently served as President Director of the Company from 2010 to 2014. He also served as President Director of PT Medifarma Laboratories, from 2015 to 2017.​ He currently serves as Senior Vice President of Unilab, Inc., and Director of several associated companies. Among his functions is the Management of Treasury Investments. Mr. Eric is also a member of the Board of Directors of Greenfield Development Corporation.​

Mr. Mariano John L. Tan, Jr. has earned a number of education degrees, such as Bachelor of Arts (BA) in Economics and Business from Lafayette College, (Pennsylvania, USA) and Master of Science in Management from the Hult International Business School, formerly Arthur D. Little Institute of Management (Massachusetts, USA). He was first appointed as Commissioner in June 2010 and was a Director from 2005 to 2010. He started his professional career as a Management Trainee at Citibank, New York, USA and later, he joined the Unilab Group as Vice President & Executive Officer in 1984. Currently,​ Mr. Tan serves as Vice Chairman of the Unilab Board of Directors, Vice Chairman of the Board of Greenfield Development Corporation, Director of Fort Bonifacio Development Corp, President of Dolmar Property Ventures Inc., Chairman of the Board and President of Dolmar Real Estate Development Corp., as well as Commissioner of PT Medifarma Laboratories.

Mr. Sonny Kalona was first appointed as Independent Commissioner in June 2010. He was re-appointed as Independent Commissioner at the AGMS held in June 2015. He obtained Master of Business Administration (MBA) from New York University (1977).

He started his professional career as Director of PT Wigo Manufacturing Pharmacists (1977). Afterwards, in 1995, he joined the Company as a Director and became President Director (1995), Vice President Commissioner (2000-2002) and a Senior Advisor to the Company (2002-2010). Currently, he serves as Chairman of the Audit Committee pursuant to the Board of Commissioner Circular Resolution on 26 January 2015 and holding executive positions at several other companies.

Mr. Sancoyo Antarikso was first appointed as Independent Commissioner at the EGMS on 30 September 2021. He earned his Bachelor of Accounting from Gadjah Mada University (1988), Master in Management from the Indonesian Institute for Management Development (1996), and Master of Business Administration (MBA) from Mt. Eliza Business School, Monash University (1997).

He began his career at PT Unilever Indonesia Tbk in 1990 and served there until his retirement in 2020. He held several senior positions during the period, including Commercial Director at PT Kimberly Lever Indonesia, Chief Audit Executive, Company Controller, and Governance & Corporate Affairs Director and Corporate Secretary of PT Unilever Indonesia Tbk. He is currently Chairman of Perkosmi (Indonesian Cosmetics Association), and serves as the Board of Patron Chair of Yayasan Save the Children Indonesia.

Mr. Jose Sumpaico Romana was first appointed as President Director of Darya-Varia at the EGMS on 20 October 2020. He earned a number of education degrees, including Bachelor of Science Degree in Commerce, majoring in Financial Management, from De la Salle University in the Philippines in 1982 and Master in Business Administration, Marketing Management from De La Salle School of Business and Economics in the Philippines in 1987. He began his career at United Laboratories, Inc. as a Product Manager (1988). Later, he was appointed as Product Director (1997) and held various important positions at Unilab, with the latest position being that of Operating Vice President, before joining Darya-Varia. In 2015 to 2020, he served as Vice President Director of Darya-Varia.

dr. Ian Martin Wibawa Kloer was first appointed as Vice President Director of Darya-Varia on EGMS, 20 October 2020. He obtained his Bachelor’s degree in Medicine from Trisakti University in 1998 and his Bachelor’s degree in Public Health from the University of Indonesia in 2001. He also took his oath as a Medical Doctor in 2001. Starting his career in PT Panarub Industry as HSE & Labor Practice Manager, and then joined in Mega Lifesciences PTY. LTD. as Ethical Products Brand Manager. He also served as Business Manager in PT Ferron Par Pharmaceuticals (Dexa Medica Group). Before joining Darya-Varia, he worked in PT Fresenius Kabi Indonesia as Vice President Transfusion and Cell Technologies (TCT), for the cluster of Indonesia, Malaysia, Singapore dan the Philippines. 

Mr. Carlos Olivares Nava was first appointed as Director of Darya-Varia in June 2009, and then reappointed at the AGMS on 15 June 2021. He obtained a number of education degrees, such as Bachelor of Arts, majoring in Economics with Magna Cum Laude from De La Salle University (Manila), in the Philippines (1975), and Bachelor of Science Degree in Commerce, majoring in Accounting. In terms of non-formal education, he successfully passed the Certified Public Accountant (CPA) board of examination in 1975 and obtained a license of Certified Public Accountant in the Philippines. He began his professional career at Unilever Philippines as a Management Trainee and held various finance posistions in Unilever Foods Division (1975-1982). Afterwards, he became a Manager of Poultry Accounting and Group Manager for Internal Audit at Pure Foods Corporation (1982-1988). Then, he joined at Cargill Philippines, Inc. and its subsidiaries as Country Controller and CFO (1988-1992). Later he joined Kraft Foods Philippines, Inc. as Finance Director (1992-1999). He began his career in Unilab as Assistant Vice President for Finance of Unilab's International Operations. Currently he serves as Senior Vice President and CFO for Unilab's International Operations, Director of Medifarma Laboratories, and President Director of PT UBC Medical Indonesia.

Mr. Angelito Celso C. Racho, Jr. was first appointed as Director in June 2010, and then reappointed at the AGMS on 3 June 2015. He obtained Bachelor of Science in Industrial Pharmacy from the University of the Philippines (1984) as well as Completed the Management Development program at the Asian Institute of Management of Management and Blended Learning Course Health Leadership, organized by the World Bank and the Asian Institute of Management (1984). He began his professional career at United Laboratories, Inc. as a Cadet Engineer at the Manufacturing Division (1985) and was later promoted to Production Manager of Unilab (1991). Afterwards, he appointed as Division Vice President an was transferred to the International Division (2005). In 2005, he joined Darya-Varia as Technical Operating Director, and served as Managing Director of PT Medifarma Laboratories (2010). Currently, he serves as Director and General Manager of PT Medifarma Laboratories, Commissioner of PT Medifarma Life Sciences, and Director of PT Etana Biotechnologies Indonesia.

Ms. Yustina Endang Setyowati was first appointed as Independent Director at the AGMS on 6 June 2017. She obtained a number of education degrees, such as Bachelor of Degree in Agricultural Industrial Engineering from Gadjah Mada University (UGM), Yogyakarta (1993) and Master Degree of Management from the Indonesian Institute for Management Development (2007). She started her professional career at PT Schering AG as Product Management (1994). Later in 2001, she joined PT Medifarma Laboratories as Product Management team and was assigned to United Pharma Vietnam as Head of Ethical Marketing & Sales (2001-2004). Afterwards, she joined Darya-Varia in 2004 and has held various positions i.e Division Manager of Corporate Product Portfolio Planning and Ethical Sales &Marketing of Gastro Division (2007-2008); Ethical Marketing Director, as well as Head of Corporate Product Portfolio Planning and Health & Regulatory Affairs. Then in 2012, she was appointed as Business Development and Corporate Planning Director of Darya-Varia.

Mr. Celso Paz Lim was first appointed as a Director at AGMS on 28 June 2022. He earned a degree in Accountancy from De La Salle University, Manila, Philippines, (1990). From 1991 to date, he also registered under the Philippine Institute of Certified Public Accountants. He started his professional experience as Auditor at various prominent public accountant’s offices, such as Ernst & Young in the Philippines for 5 years and Deloitte Touché Tohmatsu in Indonesia for 3 years. Later, he served for more than 9 years at Ernst & Young in Indonesia. In 2010, he served as Head of Internal Audit and Corporate Accounting in PT Central Cipta Murdaya. From 2011 to 2015, he joined PT Supernova/ PT Supernova Flexible Packaging as Finance Director/ Chief Financial Officer. After 4 years, he joined PT Niro Ceramic Sales Indonesia / PT Niro Ceramic Nasional Indonesia and served as Chief Financial Officer until 2022.